Portfolio Expansion, Quarterly Dividends, Fresh Partnerships, and Strong Earnings Growth - Research Report on Agilent, Life

   Portfolio Expansion, Quarterly Dividends, Fresh Partnerships, and Strong
       Earnings Growth - Research Report on Agilent, Life Technologies,
                         Mettler-Toledo, BD, and West

Editor Note: For more information about this release, please scroll to bottom

PR Newswire

NEW YORK, August 1, 2013

NEW YORK, August 1, 2013 /PRNewswire/ --

Today, Investors' Reports announced new research reports highlighting Agilent
Technologies, Inc. (NYSE: A), Life Technologies Corporation (NASDAQ: LIFE),
Mettler-Toledo International Inc. (NYSE: MTD), Becton, Dickinson and Company
(NYSE: BDX), and West Pharmaceutical Services, Inc. (NYSE: WST). Today's
readers may access these reports free of charge - including full price
targets, industry analysis and analyst ratings - via the links below.

Agilent Technologies, Inc. Research Report

On July 29, 2013, Agilent Technologies, Inc. (Agilent) announced that it will
demonstrate some of its key product at EMC 2013, the IEEE International
Symposium on Electromagnetic Compatibility, to be held from August 5 to August
9, 2013, at the Denver Convention Center in Denver, Colorado. Agilent informed
that as part of the Global EMC and SI University series, Heidi Barnes, a
Technical Expert at Agilent EEsof EDA, will present "Just How Good is Your SI
Simulator?" The Full Research Report on Agilent Technologies, Inc. - including
full detailed breakdown, analyst ratings and price targets - is available to
download free of charge at:
[http://www.investorsreports.com/report/2013-07-30/A]

--

Life Technologies Corporation Research Report

On July 25, 2013, Life Technologies Corporation (Life Technologies) announced
the expansion of its global food safety portfolio with the worldwide
distribution of the RT-qPCR assays for the detection of Norovirus GI and
Norovirus GII, Hepatitis A, and the Mengovirus Extraction Control Kit by
CEERAM (the European Centre for Expertise and Research on Microbial Agents).
Before the global distribution, the Company stated that the solutions were
available only in Europe, Middle East, and Africa. The Company's Vice
President and General Manager of Animal Health & Food Safety, Nir Nimrodi,
said, "This global distribution deal with CEERAM broadens Life Technologies'
already extensive portfolio of pathogen food safety solutions with these virus
detection kits, providing food regulatory bodies and food manufacturers with
access these high quality products." The Full Research Report on Life
Technologies Corporation - including full detailed breakdown, analyst ratings
and price targets - is available to download free of charge at:
[http://www.investorsreports.com/report/2013-07-30/LIFE]

--

Mettler-Toledo International Inc. Research Report

On July 25, 2013, Mettler-Toledo International Inc. (Mettler-Toledo) reported
Q2 2013 financial results. Net earnings per diluted share for Q2 2013 were
$2.24, higher as compared with $1.93 in Q2 2012. Adjusted EPS of $2.35
reflected an increase of 9.3% YoY. Further, the Company generated sales of
$578.7 million in Q2 2013, representing a growth of 1.5% YoY. "Market
conditions remain challenging, particularly in China. However, with continued
strong execution in our various margin improvement and cost control
initiatives, we generated good growth in EPS," said Olivier Filliol, President
and CEO of Mettler-Toledo. The Full Research Report on Mettler-Toledo
International Inc. - including full detailed breakdown, analyst ratings and
price targets - is available to download free of charge at:
[http://www.investorsreports.com/report/2013-07-30/MTD]

--

Becton, Dickinson and Company Research Report

On July 23, 2013, Becton, Dickinson and Company (BD) announced that its Board
of Directors has declared a quarterly dividend of c.$0.50 per share. The
dividend is payable on September 30, 2013, to shareholders of record as of
September 9, 2013. The Company reported that the indicated annual dividend
rate is $1.98 per share. The Full Research Report on Becton, Dickinson and
Company - including full detailed breakdown, analyst ratings and price targets
- is available to download free of charge at:
[http://www.investorsreports.com/report/2013-07-30/BDX]

--

West Pharmaceutical Services, Inc. Research Report

On July 2, 2013, West Pharmaceutical Services, Inc. (West) announced the
expansion of the NovaGuard portfolio of needle safety products. The Company
informed that the NovaGuard SA system is now part of the NovaGuard system
technology platform of syringe safety systems. According to the Company,
prospective customers began evaluating NovaGuard SA in 2012, and West is
expanding capacity to meet expected increases in market demand. Commenting on
the expansion, Graham Reynolds, Vice President, Marketing and Innovation at
West, said, "With our NovaGuard family of dependable, easy-to-use safety
systems, we are able to meet growing market demand for safe drug delivery
solutions worldwide and work together with our customers to create a healthier
world." The Full Research Report on West Pharmaceutical Services, Inc. -
including full detailed breakdown, analyst ratings and price targets - is
available to download free of charge at:
[http://www.investorsreports.com/report/2013-07-30/WST]

----

EDITOR NOTES:

1.This is not company news. We are an independent source and our views do
    not reflect the companies mentioned.
2.Information in this release is fact checked and produced on a best efforts
    basis and reviewed by a CFA. However, we are only human and are prone to
    make mistakes. If you notice any errors or omissions, please notify us
    below.
3.This information is submitted as a net-positive to companies mentioned, to
    increase awareness for mentioned companies to our subscriber base and the
    investing public.
4.If you wish to have your company covered in more detail by our team, or
    wish to learn more about our services, please contact us at
    pubco@EquityNewsNetwork.com.
5.For any urgent concerns or inquiries, please contact us at
    compliance@EquityNewsNetwork.com.
6.Are you a public company? Would you like to see similar coverage on your
    company? Send us a full investors' package to
    research@EquityNewsNetwork.com for consideration.

COMPLIANCE PROCEDURE

Content is researched, written and reviewed on a best-effort basis. This
document, article or report is prepared and authored by Equity News Network.
An outsourced research services provider has, through Chartered Financial
Analysts, only reviewed the information provided by Equity News Network in
this article or report according to the Procedures outlined by Equity News
Network. Equity News Network is not entitled to veto or interfere in the
application of such procedures by the outsourced provider to the articles,
documents or reports, as the case may be.

NOT FINANCIAL ADVICE

Equity News Network makes no warranty, expressed or implied, as to the
accuracy or completeness or fitness for a purpose (investment or otherwise),
of the information provided in this document. This information is not to be
construed as personal financial advice. Readers are encouraged to consult
their personal financial advisor before making any decisions to buy, sell or
hold any securities mentioned herein.

NO WARRANTY OR LIABILITY ASSUMED

Equity News Network is not responsible for any error which may be occasioned
at the time of printing of this document or any error, mistake or shortcoming.
No liability is accepted by Equity News Network whatsoever for any direct,
indirect or consequential loss arising from the use of this document. Equity
News Network expressly disclaims any fiduciary responsibility or liability for
any consequences, financial or otherwise arising from any reliance placed on
the information in this document. Equity News Network does not (1) guarantee
the accuracy, timeliness, completeness or correct sequencing of the
information, or (2) warrant any results from use of the information. The
included information is subject to change without notice.

InvestorsReports.com

SOURCE Investors' Reports

Contact: Kristi Saunders - CONTACT PHONE: +1-315-982-6420 (North America)